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OBJECTIVE: Favorable effects of walking levels on glycemic control have been hypothesized to be mediated through reductions
in abdominal adiposity, but this has not been well studied. We addressed this issue in patients treated for type 2 diabetes.
DESIGN: Cross-sectional analysis.
SUBJECTS: A total of 201 subjects with type 2 diabetes underwent assessments of pedometer-measured daily step counts,
blood pressure, A1C and anthropometric measures (2006--2010). Associations of anthropometric indicators of abdominal
adiposity (that is, waist circumference; waist-to-hip ratio (WHR)) with A1C were evaluated through linear regression models
adjusting for age, ethnicity, sex and the use of insulin and oral hypoglycemic agents. Models including waist circumference
were additionally adjusted for body mass index (BMI). A similar approach was used to examine A1C and daily step associations.
RESULTS: Among the 190 subjects (mean age 60 years; mean BMI 30.4kgm
 2), mean values (s.d.) for waist circumference and
WHR were respectively, 99.1cm (13.3) and 0.88 (0.07) in women, and 104.5cm (13.1) and 0.97 (0.06) in men. Mean A1C and
daily step count were respectively, 7.6% (1.4) and 5 338 steps per day (2609), and were similar for both sexes.
There was a 0.51% (95% conﬁdence interval (CI): 0.10, 0.93) A1C increment per s.d. increase in waist circumference and a 0.32%
(95% CI: 0.08, 0.56) A1C increment per s.d. increase in WHR in fully adjusted models. Each s.d. increase in daily step count was
associated with clinically signiﬁcant reductions in waist circumference and BMI. Each s.d. increase in daily steps was associated
with a 0.21% (95% CI: 0.02, 0.41) A1C decrement that declined to 0.16% (95% CI:  0.35, 0.04) with further adjustment for
anthropometric indicators of abdominal adiposity.
CONCLUSION: Higher daily steps may be associated with lower A1C values both directly and via changes in abdominal
adiposity.
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INTRODUCTION
The development of diabetes has been shown to be associated
with an increase in visceral or intra-abdominal adipose tissue
(abdominal adiposity), a decrease in s.c. adipose tissue and a
loss of muscle mass.
1 Abdominal adiposity, speciﬁcally visceral
adiposity, not only increases the risk of developing type 2
diabetes
2 but may also affect the degree of glycemic control even
after the development of diabetes.
3,4 The latter is thought to be
because of changes in insulin resistance occurring in the liver and
peripheral muscle, mediated in part by higher levels of free fatty
acids and the liberation of inﬂammatory mediators. However,
studies of the associations between abdominal adiposity and A1C
have not accounted for objective measures of physical activity.
Physical activity has been shown to improve glycemic control
among patients with type 2 diabetes.
5 In interventional studies,
walking has also been shown to be associated with reductions in
fat mass.
6 This would suggest that the favorable effects of walking
are at least partly mediated through reductions in abdominal
adiposity.
Quantiﬁcation of the relative contributions of physical activity
and abdominal adiposity with A1C may be clinically useful to
physicians and patients with type 2 diabetes. This information
would help to facilitate the development of anthropometric
and/or daily step count targets for achieving metabolic control.
In a clinical setting, anthropometric parameters provide an
approximation of visceral and s.c. abdominal fat and are
inexpensive, noninvasive techniques that can be easily applied
in clinical practice. The primary objective of this study is to better
delineate the interrelationships of abdominal adiposity and daily
step counts with A1C in adults treated for type 2 diabetes.
PATIENTS AND METHODS
Study design and population
Adults with established type 2 diabetes were recruited from McGill
University-afﬁliated outpatient clinics and presented for a baseline visit.
Data collection procedures have been detailed previously,
7,8 but are
summarized here. Participants were required to have a normal gait
9 and a
body mass index (BMI) p40kgm
 2.
10 Persons with stable cardiovascular
disease were eligible to participate, but those with other chronic medical
illnesses were excluded. Women who were pregnant or contemplating
pregnancy were also excluded.
Demographic information and medical histories were obtained for each
participant and anthropometric parameters, blood pressure and A1C were
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Frequency Questionnaire,
11 and pedometer-based estimates of physical
activity were calculated as outlined below.
Ethics statement
Procedures were approved by the Institutional Review Boards of McGill
University and participating institutions (McGill University Health Centre,
Sir Mortimer Davis Jewish General Hospital, and Centre de Sante ´ et de
Services Sociaux de la Montagne). All study participants provided written
informed consent before clinical assessments.
Anthropometric measurements
Weight and height were assessed to the nearest 0.1kg (SECA 882
electronic scale) and 0.1cm (SECA 214 stadiometer), respectively, with the
subject wearing light clothing and with shoes removed. Waist circumfer-
ence was measured midway between the iliac crest and the lower rib
margin. Hip circumference was measured at the point of greatest posterior
extension of the buttocks. The waist-to-hip ratio (WHR) was calculated by
dividing the waist circumference by the hip circumference. BMI was
calculated by dividing the weight in kilograms by the square of the height
in meters.
A1C measurement
A1C was measured from blood samples collected at each visit using the
high-pressure liquid chromatography method (Bio-Rad Variant II, High
Performance Liquid Chromatography System, Bio-Rad Laboratories,
Hercules, CA, USA).
Daily step and physical activity measurement
Daily step counts were estimated using Yamax SW-200 pedometers
(YAMASA TOKEI KEIKI CO., LTD, Tokyo, Japan), the accuracy and reliability
of which had been previously demonstrated.
12,13 Each participant was
provided with three pedometers labeled A, B and C. Participants were
instructed to wear pedometer A during waking hours for 7 consecutive
days, after which it was removed and replaced by pedometer B for another
7 consecutive days. Pedometers A, B and C were then mailed to our study
center in a prepaid, pre-addressed and padded courier envelope.
Pedometer C served to measure (false) steps registered during the mailing
process (postman steps). These postman steps were subtracted from the
step count of each of pedometers A and B, and the sum of the remaining
steps were averaged over the total time period worn (that is, 14 days). The
short, last 7 days self-administered format of the International Physical
Activity questionnaire
14 was used to assess self-reported levels of overall
physical activity and to calculate metabolic equivalents per week.
Statistical methods
Preliminary trends across the data were evaluated by generating plots of
A1C against quartiles of each anthropometric measure (Figure 1). Participant
characteristics were examined by quartiles of A1C (Table 1). Characteristics
were computed within each quartile as appropriate (that is, mean and s.d.
for continuous variables; proportions for categorical variables).
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Figure 1. (a-- d) Mean A1C by quartiles of waist circumference (a), hip circumference (b), WHR (c) and BMI (d).
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associations of each anthropometric parameter with A1C, after adjustment
for potential confounders. We identiﬁed potential confounders by
comparing the beta-coefﬁcients of the anthropometric parameter
of interest across a variety of models containing various combinations of
covariates. The covariates having the strongest impact on this beta-
coefﬁcient were identiﬁed as statistically important confounders and
retained in the ﬁnal model. Clinically important confounders such as daily
step count, age, ethnicity, sex as well as the use of insulin and oral
hypoglycemic medications were also included. Previous studies in this
population have adjusted for BMI when evaluating models containing
anthropometric parameters such as waist circumference.
3 We, therefore,
compared models with and without BMI to determine whether it was an
important confounder of the associations of interest in this study. Variables
meeting the above criteria were retained in the ﬁnal models.
Multivariate regression was also employed to evaluate the associations
between daily step counts and anthropometric parameters, as well as A1C.
Sex-speciﬁc analyses were additionally conducted.
Residual plots of the most representative models were examined to
verify that the assumptions of linear regression were met. All analyses were
conducted using the R statistical package.
15
RESULTS
A total of 201 individuals (106 men and 95 women) completed
the assessment. In all, 11 were excluded from the present analyses
because of missing A1C or pedometer data. The remaining
190 participants (87 women and 103 men) were 60 years of age
on average, with mean diabetes duration of 10 years. The cohort
was predominantly Europid (69%), with 18% reporting prevalent
cardiovascular disease (27% in men; 7% in women). The mean BMI
was 30.4kgm
 2, and the mean daily step count rounded to the
nearest hundred steps was 5300, placing participants, on average,
in the low-active category, according to the classiﬁcation scheme
developed by Tudor-Locke and Bassett.
16 The average A1C and
systolic/diastolic blood pressure were 7.6% and 137/80mmHg,
respectively. There was a greater prevalence of insulin use in the
higher quartiles of A1C (Table 1), and the mean WHR and BMI
were higher in the fourth compared with the ﬁrst quartile of A1C,
particularly among the women. The mean waist circumference
was higher in the fourth compared with the ﬁrst quartile of A1C,
particularly among the men.
Identiﬁcation of confounders
Using the approach described previously, age, ethnicity and sex
were determined to be statistically important confounders and as
such they were included in all models. Dietary covariates were
evaluated in all models but were not found to be statistically
important confounders. Though they did not signiﬁcantly impact
the associations of interest, medication use was retained in the
ﬁnal models because of their clinical importance.
Table 1. Participant characteristics (n¼190) by quartiles of HbA1c
Characteristic, mean (s.d.) Quartiles of HbA1c
1st n¼51 2nd n¼46 3rd n¼46 4th n¼47
HbA1c, (%) p6.8 6.9- -7.6 7.7- -8.2 48.2
Women, no. (%) 24 (47) 19 (41) 22 (48) 22 (47)
Age (years) 60.4 (10.6) 58.7 (9.2) 61.5 (10.7) 58.5 (11.5)
Diabetes duration (years) 5.9 (6.0) 9.6 (7.7) 12.9 (9.9) 10.6 (6.9)
Europid, no. (%) 67 (34) 74 (34) 72 (33) 64 (30)
Completed high school, no. (%) 90 (46) 89 (41) 78 (36) 83 (39)
Cardiovascular disease, no. (%) 10 (20)
a 8 (17)
b 9 (20)
b 7 (15)
a
Current tobacco use, no. (%) 4 (8)
c 5 (11)
a 4 (9)
a 5 (11)
c
Medications
Statin use, no. (%) 38 (75) 35 (76) 32 (70) 33 (70)
Insulin use, no. (%) 4 (8) 12 (26) 22 (48) 26 (55)
Metformin, no. (%) 39 (76) 42 (91) 33 (72) 34 (72)
Sulfonylurea, no. (%) 17 (33) 20 (43) 19 (41) 19 (40)
Other OHA
d, no. (%) 1 (2) 1 (2) 1 (2) 0 (0)
One OHA, no. (%) 33 (65) 18 (39) 20 (43) 17 (36)
Two OHA, no. (%) 17 (33) 25 (54) 20 (43) 24 (51)
Three OHA, no. (%) 1 (2) 3 (7) 6 (13) 6 (13)
Daily step count
e 5400 (2700) 6000 (2200) 4900 (2200) 5000 (3100)
Anthropometric parameters
Waist circumference (cm)
Women 98.4 (14.9) 96.0 (13.4) 102.3 (10.3) 99.7 (13.7)
Men 105.3 (12.2) 100.6 (14.2) 104.0 (10.6) 107.9 (14.6)
Hip circumference (cm)
Women 114.4 (14.9) 110.9 (10.6) 115.5 (10.7) 110.7 (11.6)
Men 109.6 (9.8) 106.1 (13.4) 107.1 (9.5) 109.9 (11.6)
WHR
Women 0.86 (0.06) 0.86 (0.07) 0.89 (0.06) 0.90 (0.07)
Men 0.96 (0.06) 0.95 (0.06) 0.98 (0.07) 0.98 (0.06)
BMI (kgm
 2)
Women 31.4 (6.9) 29.8 (6.0) 33.1 (5.3) 30.0 (4.7)
Men 30.0 (5.0) 28.8 (6.0) 30.2 (4.3) 30.5 (6.5)
Abbreviations: BMI, body mass index; OHA, oral hypoglycemic agents; WHR, waist-to-hip ratio.
aData for two participants missing.
bData for four participant
missing.
cData for one participants missing.
dOther OHA: meglitinides, thiazolidinediones and incretin agents.
eRounded to the nearest hundred steps.
Abdominal adiposity, daily step counts and A1C
P Manjoo et al
3
Nutrition and Diabetes (2012) 1- -6 & 2012 Macmillan Publishers LimitedAnthropometric parameters as predictors of A1C
Plots suggested a positive curvilinear association between mean
A1C and WHR quartiles (Figure 1c). This was not apparent for
waist, hip circumference or BMI (Figures 1a, b and d).
In age, ethnicity and sex-adjusted models, each s.d. increase in
waist circumference (13.4cm) was associated with a 0.26% (95%
conﬁdence interval (CI): 0.04, 0.47) higher A1C (Table 2). Further
adjustment for BMI markedly increased these associations,
whereas additional adjustment for insulin use and the number
of hypoglycemic agents being used marginally decreased the
magnitude of association. In the fully adjusted model, each s.d.
increase in waist circumference was associated with a statistically
and clinically important 0.51% (0.10, 0.93) increment in A1C.
In age-, ethnicity- and sex-adjusted models, each s.d. increase in
WHR (0.08) was associated with a 0.46% (95% CI: 0.21, 0.71)
increment in A1C (Table 2). This estimate did not change
importantly after further adjustment for BMI or daily steps. In
the fully adjusted model, the association between each s.d.
increase in WHR and A1C was 0.32 % (0.08, 0.56).
Associations of daily step count with anthropometric measures
In fully adjusted models, each s.d. increment in daily step count
(2609) was associated with clinically important decreases in BMI
and waist circumference, among both women and men (Table 3).
The decrease in WHR was statistically signiﬁcant among women
but not men.
Association of daily step count with A1C
In models adjusting for age, ethnicity, sex, insulin use and the
number of oral hypoglycemic agents being used, each s.d.
increase in daily step counts was associated with a 0.21%.
(95% CI: 0.41, 0.02) lower A1C (Table 4). Further adjustment for
either waist circumference and BMI or WHR reduced the estimates
of this association by approximately one-third, with CI that now
cross zero.
DISCUSSION
Our ﬁndings demonstrate that among adults treated for type 2
diabetes, anthropometric indicators of abdominal adiposity are
positively associated with A1C levels. Each s.d. increase in waist
circumference (13.4cm) was associated with an approximately
0.5% higher A1C in models adjusted for age, sex, ethnicity, BMI
and anti-hyperglycemic medication use. Each s.d. (0.08 unit)
increase in WHR was associated with an approximately 0.35%
higher A1C in models adjusted for age, sex and ethnicity.
Table 2. Change in A1C (95% CI) per s.d. increase in each anthropometric measure
Anthropometric measure (s.d.) All Women Men
Waist circumference (13.4cm)
Adjusted for age, ethnicity, sex 0.26 (0.04, 0.47) 0.20 ( 0.09, 0.48) 0.29 ( 0.03, 0.61)
Adjusted for age, ethnicity, sex, BMI 0.81 (0.37, 1.24) 0.81 (0.31, 1.31) 0.84 (0.04, 1.63)
Adjusted for age, ethnicity, sex, BMI, steps 0.72 (0.27, 1.17) 0.70 (0.17, 1.24) 0.78 ( 0.01, 1.58)
Adjusted for age, ethnicity, sex, BMI, steps, insulin use 0.54 (0.12, 0.97) 0.54 (0.03, 1.05) 0.62 ( 0.13, 1.36)
Adjusted for age, ethnicity, BMI, steps, insulin use, number of OHA 0.51 (0.10, 0.93) 0.55 (0.04, 1.07) 0.62 ( 0.09, 1.33)
WHR (0.08)
Adjusted for age, ethnicity, sex 0.46 (0.21, 0.71) 0.52 (0.20, 0.84) 0.41 (0.03, 0.80)
Adjusted for age, ethnicity, sex, BMI 0.48 (0.21, 0.74) 0.56 (0.23, 0.89) 0.39 ( 0.03, 0.82)
Adjusted for age, ethnicity, sex, steps 0.41 (0.15, 0.67) 0.46 (0.11, 0.81) 0.39 (0.01, 0.77)
Adjusted for age, ethnicity, sex, steps, insulin use 0.35 (0.11, 0.59) 0.40 (0.07, 0.72) 0.33 ( 0.02, 0.69)
Adjusted for age, ethnicity, sex, steps, insulin use, number of OHA 0.32 (0.08, 0.56) 0.41 (0.08, 0.75) 0.27 ( 0.08, 0.61)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; OHA, oral hypoglycemic agents; WHR, waist-to-hip ratio.
Table 3. Change in each anthropometric measure (95% CI) per s.d. increase in daily steps
a, in models adjusted for age, ethnicity, sex, insulin use and
number of OHA
Measure All Women Men
Waist, (cm)  4.6 ( 6.4,  2.8)  5.3 ( 8.2,  2.4)  4.1 ( 6.4,  1.7)
WHR  0.01 ( 0.02,  0.00)  0.03 ( 0.04,  0.01) 0 ( 0.02, 0.03)
BMI, (kgm
 2)  1.6 ( 2.4,  0.8)  1.4 ( 2.8,  0.1)  1.7 ( 2.7,  0.7)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; OHA, oral hypoglycemic agents; WHR, waist-to-hip ratio.
as.d. for daily step count: 2609
(combined); 2438 (women); 2796 (men).
Table 4. Change in A1C (with 95% CI) per s.d. increase in daily step count
a
Variables adjusted in model All Women Men
Age, ethnicity, sex, insulin, number of OHA  0.21 ( 0.41,  0.02)  0.24 ( 0.52, 0.04)  0.26 ( 0.52, 0.01)
Age, ethnicity, sex, insulin, number of OHA, waist, BMI  0.16 ( 0.37, 0.05)  0.14 ( 0.44, 0.16)  0.24 ( 0.52, 0.04)
Age, ethnicity, sex, insulin, number of OHA, WHR  0.16 ( 0.35, 0.04)  0.09 ( 0.39, 0.21)  0.24 ( 0.50, 0.02)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; OHA, oral hypoglycemic agents; WHR, waist-to-hip ratio.
aSD for daily step count: 2609
(combined); 2438 (women); 2796 (men).
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only marginally decreased by adjustment for daily step counts.
Increments of one s.d. increase in daily step counts were
associated with reductions in A1C of approximately 0.2% in
age-, ethnicity-, sex- and medication-adjusted models. Further
adjustment for anthropometric measures of abdominal adiposity
reduced the estimates of these associations by approximately
one-third and resulted in a loss of statistical signiﬁcance, though
the associations were still potentially of clinical importance.
Finally, we determined step counts to be associated with clinically
important reductions in both waist circumference and BMI among
both women and men, and with reductions in WHR only among
women.
Our analyses indicate that abdominal adiposity, as captured
by anthropometric parameters, is importantly related to A1C, even
after accounting for daily step counts. In fact, adjustment for daily
step counts resulted in only small attenuations of the associations
between anthropometric parameters and A1C. In contrast,
whereas higher step counts are associated with a lower A1C,
roughly one-third of this association is accounted for by
reductions in abdominal adiposity, according to our models.
Our ﬁndings are consistent with those of the Atherosclerosis
Risk in Communities Study study, in which persons with type 2
diabetes in the highest quartile of WHR (1.00--1.27) had a 0.8%
greater A1C compared with persons in the lowest quartile (WHR
0.64--0.93).
4 In contrast to this study, however, we additionally
examined effects of waist circumference adjusted for BMI,
accounted for daily steps and also medication use. In a recent
cross-sectional analysis of the Guangzhau Biobank Cohort Study,
among anthropometric parameters, WHR was the strongest
predictor of type 2 diabetes, higher levels of physical activity
were associated with a lower risk of type 2 diabetes, and WHR was
more strongly associated with diabetes risk than physical
activity.
17 Our study complements this work by assessing the
associations with glycemic control in a diabetic population and
accounting for physical activity through an objective measure,
pedometer-based estimates of daily step counts.
Our study highlights the importance of abdominal adiposity as
a possible determinant of A1C. Waist circumference and WHR are
highly correlated with intra-abdominal adipose tissue, which is
strongly linked to development of insulin resistance and type 2
diabetes itself.
1 This is due in part to its association with ectopic
fat and its greater lipotoxic effects through the liberation of free
fatty acids and inﬂammatory cytokines.
18- -21 It is well established
that glycemic control deteriorates over time.
22,23 This is felt to be
because of the decline in beta cell function.
24 Our ﬁndings would
suggest that abdominal adiposity is a strong determinant of A1C
even in a population being treated for type 2 diabetes, and may in
fact be an important factor that determines the degree to which
the A1C deteriorates in this population.
We demonstrated an inverse relationship between daily step
counts and A1C. Indeed, physical activity has been shown in
several studies to improve A1C.
25 However, few studies have
concurrently examined physical activity, abdominal adiposity or its
indicators, and glycemic control. Our ﬁndings indicate that
approximately one-third of the inverse association between step
counts and A1C may be explained by lower levels of abdominal
adiposity. In a Cochrane review of exercise interventions for type 2
diabetes, 14 trials were evaluated but only two studies reported
on changes in visceral adipose tissue. The latter was signiﬁcantly
reduced in the exercise intervention compared with the control
group.
26,27 Consideration of these ﬁndings in combination with
ours, supports the role of abdominal adiposity as a partial
mediator of the reductions in A1C associated with increasing daily
step counts.
In our study, adjustment for WHR or waist circumference
decreased the magnitude of the association of daily step counts
with A1C from  0.21% per s.d. increase in step count to  0.16%.
Although the latter fell just below the threshold for statistical
signiﬁcance, these data suggest that higher daily step counts may
be associated with a lower A1C independently of abdominal
adiposity. Potential mechanisms for this might include an
alleviation of the defect in insulin-stimulated glycogen metabo-
lism in skeletal muscle, improvement in postprandial hyperglyce-
mia by improving postprandial insulin secretion and lowering
of hepatic glucose production.
28- -30
Our analyses offer a potential mechanistic explanation for the
beneﬁts of increasing daily step count levels in the management
of type 2 diabetes. Speciﬁcally higher daily step counts are
clinically associated with a smaller waist circumference, which
in turn is associated with lower A1C levels. There was also a
suggestion of a direct association between higher step counts and
a lower A1C, independent of the associated changes in adiposity.
These proposed mechanisms need to be evaluated further in
intervention studies. The ﬁndings of this study, imply that there
may be an opportunity for patients with type 2 diabetes to
leverage the impact of higher daily step counts on waist
circumference by walking more, reducing their waist circumfer-
ence, and thereby improving their glycemic control. Further, they
may also achieve direct (adiposity-independent) beneﬁts of
physical activity on A1C as well as important reductions in blood
pressure, as we have previously demonstrated.
8
The current study is limited by its cross-sectional nature, and
potentially by its sample size. Attempts to minimize measurement
error were taken by applying consistent and standardized
methods for measuring blood pressure and HbA1c. We used
anthropometric measures of body fat distribution speciﬁcally
because they are cheaper, less invasive, more acceptable
to patients and therefore more practical in a clinical setting.
This might be considered a limitation as the latter are less
accurate than radiological estimations of body fat distribution.
Some studies suggest that the Yamax Digiwalker SW-200 might
underestimate counted steps at higher BMIs.
31,32 However, these
underestimates if they did occur are likely to have been similar
across participants, and therefore unlikely to affect the demon-
strated associations. Furthermore, our study participants were
carefully trained on how to position the pedometer on their
waistband or belt so as to ensure that it was placed in a vertical
position. In addition, all pedometers registered a reading between
nineteen and twenty-one when they were checked for accuracy
by comparing their reading with twenty counted steps.
Our cohort was fairly sedentary with average daily step counts
of approximately 5000. Because our associations were limited to
these lower levels of physical activity, it is possible that the
strength of the association between physical activity and A1C
might be underestimated. Finally, while we attempted to adjust
for all clinically and statistically important confounders, we may
not have captured all such variables. Our ﬁndings need to be
explored further in pedometer-based intervention trials. Despite
these limitations, this is the only study, of which we are aware,
that has employed objective measures of walking in examining
the associations between anthropometric indicators of abdominal
adiposity and A1C.
In summary, our study suggests that abdominal adiposity is an
important determinant of A1C in adults treated for type 2 diabetes
even after adjustment for daily step counts and medications. Daily
step counts are inversely related to A1C and about one-third
of this association may be explained by abdominal adiposity. Our
ﬁndings provide quantiﬁcation of the associations of decreasing
waist size and increasing daily step counts on A1C levels among
adults treated for type 2 diabetes.
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